AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Research from University of Marburg broadens understanding of angioplasty.

Women's Health Weekly

| October 02, 2008 | COPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

In this recently published study, investigators in Marburg, Germany conducted a study "To determine exemplarily the amount of DNA damage and the repair kinetics after interventional radiologic procedures by using visualization of foci of the phosphorylated form of the H2AX histone variant (gamma H2AX) to quantify DNA double-strand breaks (DSBs) at percutaneous transluminal angioplasty (PTA) of the lower limb arteries. After local ethics committee approval and written informed consent were obtained, five patients (two women, three men; mean age, 64.4 years; age range, 45 - 76 years) scheduled for computed tomography (CT) and 20 patients (six women, 14 men; mean age, 68.5 years; age range, 53 - 85 years) scheduled for PTA of lower limb arteries were prospectively entered into the study."

"Blood samples were taken before the first exposure to ionizing radiation and 5 minutes, 1 hour, 6 hours, and 24 hours after the last exposure. Additional samples were taken from the irradiated limb ( femoral vein) of three patients who underwent PTA - before the first radiation exposure, 5 and 10 minutes after the first exposure, and 5 minutes after the last exposure. Lymphocytes were isolated, fixed, and stained with anti-gamma H2AX antibody, and gamma H2AX focus yields were determined with fluorescence microscopy. Data were analyzed with linear regression and two-sample F tests. Mean increase in number of gamma H2AX foci after CT (7.78 per 1 Gy center dot cm) depended linearly on dose- length product (r = 0.997). Number of foci reached background levels within 24 hours. Mean numbers of gamma H2AX foci per cell increased by factors of 4.08 - 20.67 in blood samples taken 5 ...

Related articles from newspapers, magazines, journals, and more
Fluosol approved for marketing by FDA: new drug to improve safety and efficacy...
Press release article from: PR Newswire January 4, 1990 700+ words
...NEW DRUG TO IMPROVE SAFETY AND EFFICACY OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) LOS ANGELES...ischemia of the heart muscle that occurs during percutaneous transluminal coronary angioplasty or "balloon" angioplasty...
percutaneous transluminal coronary angioplasty (PTCA)
Reference information from: The Mosby Medical Encyclopedia October 1, 1996 700+ words
The Mosby Medical Encyclopedia 10-01-1996 percutaneous transluminal coronary angioplasty (PTCA), a technique to treat heart disease and chest pain (angina pectoris). Fatty material (plaques...
The experiences of patients undergoing percutaneous transluminal coronary...
Magazine article from: Connect: The World of Critical Care Nursing Page, Michael Jackman, Katherine Snowden, Patricia December 22, 2008 700+ words
...983 deaths, totalling 17% of all recorded deaths (Australian Institute of Health and Welfare, 2009). Percutaneous transluminal coronary angioplasty (PTCA) and insertion of stents in patients with narrowed coronary arteries, due to...
PTA for Intracranial Atherosclerotic Stenoses.(percutaneous transluminal...
Newspaper article from: Neurology Alert Caronna, John J. July 1, 1999 700+ words
...al. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999;30: 1065-1069. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) has been used widely and successfully to treat atherosclerotic stenoses in the coronary...
... In November 2006, CMS determined that percutaneous transluminal angioplasty...
Magazine article from: Healthcare Financial Management August 1, 2008 700+ words
... In November 2006, CMS determined that percutaneous transluminal angioplasty (PTA) and stenting of intracranial arteries are reasonable and necessary for treatment of cerebral artery stenosis...
Market Forecasts Available for the European Percutaneous Transluminal Coronary...
Press release article from: Business Wire November 2, 2006 700+ words
...c44478) has announced the addition of European Markets for PTCA Balloons to their offering. The European percutaneous transluminal coronary angioplasty (PTCA) balloon market, comprising both normal and cutting balloons, was valued in...
PTCA prices still moving down. (Price Survey).(percutaneous transluminal...
Newspaper article from: Hospital Materials Management June 1, 2002 700+ words
...catheterization laboratories. For them, catheters represent a significant piece of the supply budget. The percutaneous transluminal coronary angioplasty (PTCA) balloon catheter is still a strong physician preference item, and several...
Prices reflect drop in PTCA use.(Price Survey)(Percutaneous Transluminal...
Newspaper article from: Hospital Materials Management September 1, 2004 700+ words
...entered the market in recent years, the real scientific leap has been the introduction of cardiac stents. The percutaneous transluminal coronary angioplasty (PTCA) balloon catheter, some say, is on the way to becoming a mere delivery device...
For more facts and information, see all results

Source: HighBeam Research, Research from University of Marburg broadens understanding of...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA